Additional file 1: of Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation

Additional file 1: of MSC stimulate ovarian tumor growth during intercellular communication but reduce tumorigenicity after fusion with ovarian cancer cells

Catharina Melzer (4764342)
Juliane von der Ohe (4764339)
Ralf Hass (283575)

October 2018

Figure S1. Dose-dependent response to carboplatin was tested in SK-OV-3GFP control cells and compare...

Additional file 5: Figure S4. of Cisplatin triggers cancer stem cell enrichment in platinum-resistant cells through NF-κB-TNFα-PIK3CA loop

Bhushan Thakur (4614046)
Pritha Ray (279482)

November 2017

Cisplatin induced NF-κB and its physical interaction with PIK3CA promoter in TOV21G and SKOV3 cells....

Additional file 8: of FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients

Renata Tassi (4013084)
Paola Todeschini (528553)
Eric Siegel (48076)
Stefano Calza (23543)
Paolo Cappella (819025)
Laura Ardighieri (4013102)
Moris Cadei (4013087)
Mattia Bugatti (4013078)
Chiara Romani (669556)
Elisabetta Bandiera (669559)
Laura Zanotti (669558)
Laura Tassone (4013096)
Donatella Guarino (4013081)
Concetta Santonocito (4013090)
Ettore Capoluongo (848071)
Luca Beltrame (67207)
Eugenio Erba (170865)
Sergio Marchini (170863)
Maurizio DâIncalci (4013105)
Carla Donzelli (4013093)
Alessandro Santin (4013075)
Sergio Pecorelli (369564)
Enrico Sartori (669560)
Eliana Bignotti (669562)
Franco Odicino (4013099)
Antonella Ravaggi (369560)

May 2017

Figure S5: Volcano plot displaying differential expressed genes between siFOXM1 and siControl OSPC2 ...

Additional file 3: of Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation

An-Yue Wu (6636974)
Li-Ying Gu (6636977)
Wei Cang (6636980)
Meng-Xing Cheng (6636983)
Wen-Jing Wang (769627)
Wen Di (384960)
Lei Huang (35191)
Li-Hua Qiu (6636986)

April 2019

Figure S3. Fn14 inhibits cisplatin resistance in HGSOC primary cancer cells with p53-R248Q. (A)-(D) ...

Additional file 4: of Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation

An-Yue Wu (6636974)
Li-Ying Gu (6636977)
Wei Cang (6636980)
Meng-Xing Cheng (6636983)
Wen-Jing Wang (769627)
Wen Di (384960)
Lei Huang (35191)
Li-Hua Qiu (6636986)

April 2019

Figure S4. Fn14 inhibits cisplatin resistance in HGSOC primary cancer cells with p53-R248Q. (A)-(C) ...

Additional file 6: of Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation

An-Yue Wu (6636974)
Li-Ying Gu (6636977)
Wei Cang (6636980)
Meng-Xing Cheng (6636983)
Wen-Jing Wang (769627)
Wen Di (384960)
Lei Huang (35191)
Li-Hua Qiu (6636986)

April 2019

Figure S6. Overexpression Fn14 alleviates cisplatin resistance in vivo. (A) Statistical data of West...

Additional file 5: of Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation

An-Yue Wu (6636974)
Li-Ying Gu (6636977)
Wei Cang (6636980)
Meng-Xing Cheng (6636983)
Wen-Jing Wang (769627)
Wen Di (384960)
Lei Huang (35191)
Li-Hua Qiu (6636986)

April 2019

Figure S5. Fn14 could reduce the formation of Mdm2-p53-R248Q-Hsp90. (A)-(B) Statistical data of West...

Additional file 2: of Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation

An-Yue Wu (6636974)
Li-Ying Gu (6636977)
Wei Cang (6636980)
Meng-Xing Cheng (6636983)
Wen-Jing Wang (769627)
Wen Di (384960)
Lei Huang (35191)
Li-Hua Qiu (6636986)

April 2019

Figure S2. Characterization of primary HGSOC cells and identification of p53 status in primary cells...

Additional file 1: Table S1. of Cisplatin triggers cancer stem cell enrichment in platinum-resistant cells through NF-κB-TNFα-PIK3CA loop

Bhushan Thakur (4614046)
Pritha Ray (279482)

November 2017

List of protein identified exclusively in A2780-CisR control (untreated) cells. Table S2. List of pr...

Additional file 1: of Wounding promotes ovarian cancer progression and decreases efficacy of cisplatin in a syngeneic mouse model

Yooyoung Lee (5483093)
Alexandra Kollara (347244)
Taymaa May (5483090)
Theodore Brown (4876369)

July 2018

Table S1. Luciferase activity levels of clonally selected ID8 cells stably transfected with PB-CAG-L...

Additional file 2: of DKK1 is a potential novel mediator of cisplatin-refractoriness in non-small cell lung cancer cell lines

Hogir Salim (3547547)
Dali Zong (3547541)
Petra Hååg (3547544)
Metka Novak (706791)
Birgitta Mörk (3547553)
Rolf Lewensohn (809379)
Lovisa Lundholm (3547550)
Kristina Viktorsson (2203072)

September 2015

A plasmid carrying FMN1 was transfected into NSCLC U-1810 cells for 24 h, for which Lipofectamine-on...

Additional file 1: of Deregulation of the spindle assembly checkpoint is associated with paclitaxel resistance in ovarian cancer

Taryne Chong (5060453)
Amila Sarac (5060456)
Cindy Yao (3440612)
Linda Liao (3440618)
Nicola Lyttle (3440624)
Paul Boutros (196570)
John Bartlett (602286)
Melanie Spears (3440621)

April 2018

Table S1. List of significant genes illustrating enrichment and depletion of genes across 3 ovarian ...

Additional file 7: of Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38

Katharina Gohr (4571839)
Alexandra Hamacher (534446)
Laura Engelke (1867372)
Matthias Kassack (2160217)

November 2017

Characterization of MDA-MB231 and cisplatin-resistant MDA-MB231CisR. MDA-MB231 and cisplatin-resista...

Additional file 4: of HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells

J. Ribeiro (3510533)
C. Schorl (3510527)
N. Yano (3510530)
N. Romano (3510536)
K. Kim (2516335)
R. Singh (402342)
R. Moore (2296453)

May 2016

Reduced transcriptional regulation by cisplatin in SKOV3-C1 cells. Scatterplots of all transcripts u...

Additional file 5: of HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells

J. Ribeiro (3510533)
C. Schorl (3510527)
N. Yano (3510530)
N. Romano (3510536)
K. Kim (2516335)
R. Singh (402342)
R. Moore (2296453)

May 2016

Overexpression of HE4 suppresses cisplatin-mediated activation of p38 and ERK. (A) SKOV3-NV, SKOV3-C...

Additional file 1: of MSC stimulate ovarian tumor growth during intercellular communication but reduce tumorigenicity after fusion with ovarian cancer cells

Catharina Melzer (4764342)
Juliane von der Ohe (4764339)
Ralf Hass (283575)

October 2018

Figure S1. Dose-dependent response to carboplatin was tested in SK-OV-3GFP control cells and compare...

Additional file 5: Figure S4. of Cisplatin triggers cancer stem cell enrichment in platinum-resistant cells through NF-κB-TNFα-PIK3CA loop

Bhushan Thakur (4614046)
Pritha Ray (279482)

November 2017

Cisplatin induced NF-κB and its physical interaction with PIK3CA promoter in TOV21G and SKOV3 cells....

Additional file 8: of FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients

Renata Tassi (4013084)
Paola Todeschini (528553)
Eric Siegel (48076)
Stefano Calza (23543)
Paolo Cappella (819025)
Laura Ardighieri (4013102)
Moris Cadei (4013087)
Mattia Bugatti (4013078)
Chiara Romani (669556)
Elisabetta Bandiera (669559)
Laura Zanotti (669558)
Laura Tassone (4013096)
Donatella Guarino (4013081)
Concetta Santonocito (4013090)
Ettore Capoluongo (848071)
Luca Beltrame (67207)
Eugenio Erba (170865)
Sergio Marchini (170863)
Maurizio DâIncalci (4013105)
Carla Donzelli (4013093)
Alessandro Santin (4013075)
Sergio Pecorelli (369564)
Enrico Sartori (669560)
Eliana Bignotti (669562)
Franco Odicino (4013099)
Antonella Ravaggi (369560)

May 2017

Figure S5: Volcano plot displaying differential expressed genes between siFOXM1 and siControl OSPC2 ...

Additional file 3: of Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation

An-Yue Wu (6636974)
Li-Ying Gu (6636977)
Wei Cang (6636980)
Meng-Xing Cheng (6636983)
Wen-Jing Wang (769627)
Wen Di (384960)
Lei Huang (35191)
Li-Hua Qiu (6636986)

April 2019

Figure S3. Fn14 inhibits cisplatin resistance in HGSOC primary cancer cells with p53-R248Q. (A)-(D) ...

Additional file 4: of Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation

An-Yue Wu (6636974)
Li-Ying Gu (6636977)
Wei Cang (6636980)
Meng-Xing Cheng (6636983)
Wen-Jing Wang (769627)
Wen Di (384960)
Lei Huang (35191)
Li-Hua Qiu (6636986)

April 2019

Figure S4. Fn14 inhibits cisplatin resistance in HGSOC primary cancer cells with p53-R248Q. (A)-(C) ...

Additional file 6: of Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation

An-Yue Wu (6636974)
Li-Ying Gu (6636977)
Wei Cang (6636980)
Meng-Xing Cheng (6636983)
Wen-Jing Wang (769627)
Wen Di (384960)
Lei Huang (35191)
Li-Hua Qiu (6636986)

April 2019

Figure S6. Overexpression Fn14 alleviates cisplatin resistance in vivo. (A) Statistical data of West...

Additional file 5: of Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation

An-Yue Wu (6636974)
Li-Ying Gu (6636977)
Wei Cang (6636980)
Meng-Xing Cheng (6636983)
Wen-Jing Wang (769627)
Wen Di (384960)
Lei Huang (35191)
Li-Hua Qiu (6636986)

April 2019

Figure S5. Fn14 could reduce the formation of Mdm2-p53-R248Q-Hsp90. (A)-(B) Statistical data of West...

Additional file 2: of Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation

An-Yue Wu (6636974)
Li-Ying Gu (6636977)
Wei Cang (6636980)
Meng-Xing Cheng (6636983)
Wen-Jing Wang (769627)
Wen Di (384960)
Lei Huang (35191)
Li-Hua Qiu (6636986)

April 2019

Figure S2. Characterization of primary HGSOC cells and identification of p53 status in primary cells...

Additional file 1: Table S1. of Cisplatin triggers cancer stem cell enrichment in platinum-resistant cells through NF-κB-TNFα-PIK3CA loop

Bhushan Thakur (4614046)
Pritha Ray (279482)

November 2017

List of protein identified exclusively in A2780-CisR control (untreated) cells. Table S2. List of pr...

Additional file 1: of Wounding promotes ovarian cancer progression and decreases efficacy of cisplatin in a syngeneic mouse model

Yooyoung Lee (5483093)
Alexandra Kollara (347244)
Taymaa May (5483090)
Theodore Brown (4876369)

July 2018

Table S1. Luciferase activity levels of clonally selected ID8 cells stably transfected with PB-CAG-L...

Additional file 2: of DKK1 is a potential novel mediator of cisplatin-refractoriness in non-small cell lung cancer cell lines

Hogir Salim (3547547)
Dali Zong (3547541)
Petra Hååg (3547544)
Metka Novak (706791)
Birgitta Mörk (3547553)
Rolf Lewensohn (809379)
Lovisa Lundholm (3547550)
Kristina Viktorsson (2203072)

September 2015

A plasmid carrying FMN1 was transfected into NSCLC U-1810 cells for 24 h, for which Lipofectamine-on...

Additional file 1: of Deregulation of the spindle assembly checkpoint is associated with paclitaxel resistance in ovarian cancer

Taryne Chong (5060453)
Amila Sarac (5060456)
Cindy Yao (3440612)
Linda Liao (3440618)
Nicola Lyttle (3440624)
Paul Boutros (196570)
John Bartlett (602286)
Melanie Spears (3440621)

April 2018

Table S1. List of significant genes illustrating enrichment and depletion of genes across 3 ovarian ...

Additional file 7: of Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38

Katharina Gohr (4571839)
Alexandra Hamacher (534446)
Laura Engelke (1867372)
Matthias Kassack (2160217)

November 2017

Characterization of MDA-MB231 and cisplatin-resistant MDA-MB231CisR. MDA-MB231 and cisplatin-resista...

Additional file 4: of HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells

J. Ribeiro (3510533)
C. Schorl (3510527)
N. Yano (3510530)
N. Romano (3510536)
K. Kim (2516335)
R. Singh (402342)
R. Moore (2296453)

May 2016

Reduced transcriptional regulation by cisplatin in SKOV3-C1 cells. Scatterplots of all transcripts u...

Additional file 5: of HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells

J. Ribeiro (3510533)
C. Schorl (3510527)
N. Yano (3510530)
N. Romano (3510536)
K. Kim (2516335)
R. Singh (402342)
R. Moore (2296453)

May 2016

Overexpression of HE4 suppresses cisplatin-mediated activation of p38 and ERK. (A) SKOV3-NV, SKOV3-C...

Additional file 1: of MSC stimulate ovarian tumor growth during intercellular communication but reduce tumorigenicity after fusion with ovarian cancer cells

Catharina Melzer (4764342)
Juliane von der Ohe (4764339)
Ralf Hass (283575)

October 2018

Figure S1. Dose-dependent response to carboplatin was tested in SK-OV-3GFP control cells and compare...

Additional file 5: Figure S4. of Cisplatin triggers cancer stem cell enrichment in platinum-resistant cells through NF-κB-TNFα-PIK3CA loop

Bhushan Thakur (4614046)
Pritha Ray (279482)

November 2017

Cisplatin induced NF-κB and its physical interaction with PIK3CA promoter in TOV21G and SKOV3 cells....

Additional file 8: of FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients

Renata Tassi (4013084)
Paola Todeschini (528553)
Eric Siegel (48076)
Stefano Calza (23543)
Paolo Cappella (819025)
Laura Ardighieri (4013102)
Moris Cadei (4013087)
Mattia Bugatti (4013078)
Chiara Romani (669556)
Elisabetta Bandiera (669559)
Laura Zanotti (669558)
Laura Tassone (4013096)
Donatella Guarino (4013081)
Concetta Santonocito (4013090)
Ettore Capoluongo (848071)
Luca Beltrame (67207)
Eugenio Erba (170865)
Sergio Marchini (170863)
Maurizio DâIncalci (4013105)
Carla Donzelli (4013093)
Alessandro Santin (4013075)
Sergio Pecorelli (369564)
Enrico Sartori (669560)
Eliana Bignotti (669562)
Franco Odicino (4013099)
Antonella Ravaggi (369560)

May 2017

Figure S5: Volcano plot displaying differential expressed genes between siFOXM1 and siControl OSPC2 ...

Additional file 1: of Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation

Abstract

Extracted data

Additional file 1: of Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation

Abstract

Extracted data

Related items

Related items